Researchers from Moffitt Cancer Center have found a new way to boost cancer immunotherapy by targeting a protein called ...
SPP1+ macrophages identified as key drivers and therapeutic targets in colorectal cancer progression
(B) Venn diagrams of common DEGs up- or down ... and immunosuppressive pathways. These macrophages interact with other cells through the SPP1-CD44, SPP1- PTGER4, and SPP1 a4b1 complex axes ...
Researchers have found a new way to boost cancer immunotherapy by targeting a protein called macrophage receptor with collagenous structure, or MARCO. Their study shows that blocking MARCO in ...
6d
News-Medical.Net on MSNTargeting MARCO enhances cancer immunotherapy effectivenessResearchers from Moffitt Cancer Center have found a new way to boost cancer immunotherapy by targeting a protein called ...
New injectable hydrogel regulates immune cell metabolism, reducing inflammation and slowing rheumatoid arthritis progression.
Researchers from Moffitt Cancer Center have found a new way to boost cancer immunotherapy by targeting a protein called macrophage receptor with collagenous structure, or MARCO. Their study, published ...
A research team from north China's Tianjin University has developed a new type of injectable hydrogel that can regulate ...
Researchers from Moffitt Cancer Center have found a new way to boost cancer immunotherapy by targeting a protein called macrophage receptor with ...
Here are five recent innovative bioprinting and bioink studies that are building synthetic biological structures.
Age-Related Changes in Male Fibroblasts Increase Treatment-Resistant Melanoma Sep. 6, 2024 — Age-related changes in the fibroblasts, cells that create the skin's structure, contribute to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results